Suspended
A Single Arm Study of Efficacy and Functional Quality of Life in Patients Treated With Transoral Robotic Surgery for Oropharyngeal and Supraglottic Squamous Cell Carcinoma
What is being tested
Transoral robotic surgery
Procedure
Who is being recruted
Carcinoma, Squamous Cell+5
+ Head and Neck Neoplasms
+ Neoplasms
Over 18 Years
+3 Eligibility Criteria
How is the trial designed
Treatment Study
Interventional
Study Start: March 2013
Summary
Principal SponsorKatherine L Fedder
Last updated: February 9, 2024
Sourced from a government-validated database.Claim as a partner
Study start date: March 1, 2013
Actual date on which the first participant was enrolled.The purpose of this study is to learn more about the outcomes of treatment of throat and voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option involving the use of the da Vinci surgical robot to remove these cancers through the mouth.
Principal SponsorKatherine L Fedder
Last updated: February 9, 2024
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
110 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Carcinoma, Squamous CellHead and Neck NeoplasmsNeoplasmsNeoplasms by Histologic TypeNeoplasms by SiteNeoplasms, Glandular and EpithelialSquamous Cell Carcinoma of Head and NeckCarcinoma
Criteria
2 inclusion criteria required to participate
Adult male or female
Diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma
1 exclusion criteria prevent from participating
Metastatic disease
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalTransoral robotic surgery
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
University of Virginia Health System
Charlottesville, United StatesOpen University of Virginia Health System in Google MapsSuspendedOne Study Center